Transcription Factor Binder

Professional transcription factor binding site prediction using Position Weight Matrices from JASPAR, TRANSFAC, and HOCOMOCO databases.

PWM Algorithm: S = Σ log₂(P(bₖ|TF)/P(bₖ|background))

The Position Weight Matrix (PWM) score S for a sequence of length L is calculated as: S = Σk=1L log₂(P(bₖ|TF)/P(bₖ|background)) where bₖ is the base at position k. Scores are converted to p-values using extreme value distribution.

Professional Features:

  • True PWM Algorithm: Uses Position Weight Matrices from JASPAR/TRANSFAC
  • Statistical Significance: Calculates p-values and E-values for each prediction
  • Multiple Testing Correction: Applies Bonferroni, FDR, and Holm-Bonferroni corrections
  • Background Models: Uniform, genomic, and Markov chain background models
Enter DNA sequence (only A, T, G, C characters). Maximum length: 5,000 bp.
Length: 0
GC Content: 0%
A/T Content: 0%
Choose transcription factor motif database
Model for calculating expected background frequencies
Maximum p-value for reporting hits
Method for correcting multiple hypothesis testing
Maximum number of results to display

Running advanced PWM scanning with statistical analysis...

Initializing...

Scientific Methodology

Position Weight Matrix Algorithm

The PWM score S for a sequence segment s of length L aligned with a PWM M is calculated as:

S(s, M) = Σi=1L log₂(Mi,bi / bbi)

where Mi,b is the frequency of base b at position i in aligned binding sites, and bb is the background frequency of base b.

Statistical Significance Calculation

P-values are calculated using the theoretical distribution of PWM scores under the null hypothesis:

Extreme Value Distribution (EVD) approximation:

P(S ≥ x) ≈ 1 - exp(-K * L * exp(-λx))

where λ and K are parameters estimated from the PWM and background model.

E-value calculation: E = N * P(S ≥ x), where N is the number of tests.

Multiple Testing Correction

We apply rigorous multiple testing corrections to control false discoveries:

  • Bonferroni: padj = p × m (most conservative)
  • Holm-Bonferroni: Step-down procedure, less conservative
  • Benjamini-Hochberg FDR: Controls expected proportion of false positives

About Transcription Factor Binding Site Prediction

What is TFBS Prediction?

Transcription Factor Binding Site (TFBS) prediction is a computational method to identify specific DNA sequences where transcription factors (TFs) are likely to bind and regulate gene expression. These predictions are essential for understanding gene regulatory networks and identifying potential regulatory elements in genomes.

Database Sources

This tool uses Position Weight Matrices (PWMs) derived from experimentally validated transcription factor binding sites. The primary sources include:

  • JASPAR CORE 2022: Open-access database of curated, non-redundant transcription factor binding profiles
  • HOCOMOCO v11: Comprehensive collection of human and mouse transcription factor binding models
  • TRANSFAC Professional: Manually curated database of eukaryotic transcription factors and their DNA binding sites
Experimental Validation Methods

Computational predictions should be validated experimentally. Common validation methods include:

  • ChIP-seq: Chromatin immunoprecipitation followed by sequencing
  • EMSA: Electrophoretic mobility shift assay
  • DNase I hypersensitivity: Identifying open chromatin regions
  • SELEX: Systematic evolution of ligands by exponential enrichment

Frequently Asked Questions

Computational TFBS prediction typically has high sensitivity but lower specificity compared to experimental methods like ChIP-seq. Accuracy varies depending on the transcription factor, with some TFs having well-defined binding motifs (accuracy up to 80-90%) while others have more degenerate motifs (accuracy 50-70%). Predictions are most reliable when combined with evolutionary conservation data and experimental validation.

The p-value threshold represents the statistical significance cutoff for reporting predicted binding sites. A p-value of 0.01 means there's a 1% probability that the observed match occurred by chance given the background model. Lower p-values (e.g., 0.001) are more stringent and reduce false positives but may miss some real binding sites. The choice of threshold depends on your analysis goals - use stringent thresholds for validation studies and more lenient thresholds for exploratory analyses.

  • Uniform background: Use when you have no information about sequence composition or when comparing across different genomic regions
  • Human genomic background: Use for human promoter/enhancer analysis when you expect typical human nucleotide frequencies
  • Markov chain models: Use when your sequence has non-random nucleotide distributions or specific compositional biases
  • Custom background: Best option when you have a specific set of control sequences from your experimental system
For most analyses of human promoter regions, the human genomic background is recommended.

Overlapping or clustered TF binding sites are biologically meaningful and often indicate:
  1. Competitive binding: Different TFs competing for overlapping sites
  2. Cooperative regulation: Multiple TFs working together in regulatory complexes
  3. Regulatory hotspots: Dense clusters of binding sites forming enhancers or promoters
  4. Redundant regulation: Multiple TFs with similar binding specificities
Such clusters are often functionally important and may indicate key regulatory regions.

Yes, with certain considerations:
  • Conserved TFs: Many transcription factors are conserved across species, so human TF motifs often work for mouse, rat, and other mammals
  • Background model: Use the uniform background model or calculate species-specific nucleotide frequencies
  • Database selection: Choose TFs known to be conserved in your species of interest
  • Validation: Always validate predictions with species-specific experimental data when available
For optimal results with non-human species, consider using species-specific PWM databases if available.

  • Sequence context: PWMs don't capture long-range dependencies or chromatin context
  • Cooperativity: Doesn't account for TF-TF interactions or cooperative binding
  • Cell-type specificity: TF binding is cell-type specific, but PWMs represent general binding preferences
  • Post-translational modifications: Doesn't consider modifications that affect TF binding
  • DNA shape: Ignores DNA structural features that influence binding
  • Dynamic binding: Doesn't capture transient or condition-specific binding events
These limitations mean computational predictions should be considered as hypotheses requiring experimental validation.

  • E-value (Expected value): The number of hits with the same or better score expected by chance in a database search. Lower E-values are better. E-value < 0.01 is generally considered significant.
  • q-value (False discovery rate): The estimated proportion of false positives among hits with this q-value or better. q-value < 0.05 means less than 5% false discoveries.
  • Interpretation guidelines:
    • q < 0.001: Highly significant - strong evidence for TF binding
    • 0.001 ≤ q < 0.01: Very significant - good evidence for TF binding
    • 0.01 ≤ q < 0.05: Significant - moderate evidence for TF binding
    • q ≥ 0.05: Not significant - weak or no evidence for TF binding

Recommended sequence lengths for different analyses:
  • Core promoter analysis: -200 to +50 bp relative to transcription start site (TSS)
  • Full promoter analysis: -1000 to +200 bp relative to TSS
  • Enhancer analysis: 500-2000 bp regions identified by chromatin marks
  • General scanning: 500-2000 bp sequences of interest
For this tool, sequences between 100 and 5000 bp work best. Longer sequences increase computation time but provide more context for identifying regulatory regions.

For novel transcription factors without known binding motifs:
  1. Homology-based prediction: If similar TFs with known motifs exist, their PWMs may provide reasonable approximations
  2. De novo motif discovery: Use tools like MEME or HOMER on sets of co-regulated genes or ChIP-seq peaks
  3. Experimental determination: Methods like protein binding microarrays (PBMs) or SELEX are needed to determine binding specificities
  4. Structure-based prediction: For TFs with known DNA-binding domain structures, computational docking may predict preferred sequences
This tool requires pre-existing PWM models, so it cannot predict binding sites for completely novel TFs.

Strategies to improve prediction accuracy:
  • Combine multiple prediction tools: Use consensus from different algorithms
  • Integrate evolutionary conservation: Focus on predictions in evolutionarily conserved regions
  • Use cell-type specific data: Incorporate DNase-seq or ATAC-seq data to identify accessible chromatin
  • Consider chromatin marks: Use histone modification data to identify active regulatory regions
  • Experimental validation: Always validate key predictions experimentally
  • Use appropriate thresholds: Adjust p-value and q-value thresholds based on your specific needs
  • Consider sequence context: Account for GC content and other sequence features
Remember that computational predictions are hypotheses that require experimental validation for confirmation.